Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jullien

Showing results (1041-1050 of 1,158) with videos related to

Pageof 116
Sort By:
Dermatology (Basel, Switzerland)|February 3, 2021
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort PsobioteqFlorence Assan, Florence Tubach, Hugo Arlegui, et al.
The Journal of Cell Biology|August 14, 2023
Presynapses contain distinct actin nanostructuresDominic Bingham, Channa Elise Jakobs, Florian Wernert, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaImke H Bartelink, Rada M Savic, Grant Dorsey, et al.
Current Alzheimer Research|June 25, 2005
JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathwayFrédéric Checler, Checler Frédéric, Cristine Alves da Costa, et al.
Nature Communications|December 1, 2021
Engineering of a fluorescent chemogenetic reporter with tunable color for advanced live-cell imagingHela Benaissa, Karim Ounoughi, Isabelle Aujard, et al.
Blood Advances|January 4, 2018
Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in miceMarijn A Gillissen, Greta de Jong, Martijn Kedde, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2016
New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseasesL Méry-Bossard, K Bagny, G Chaby, et al.
Oncoimmunology|June 28, 2021
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell responseDhon Roméo Makanga, Maxime Jullien, Gaëlle David, et al.
JAMA Dermatology|June 21, 2023
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic CellulitisJohanna Morot, Ester Del Duca, Marine Chastagner, et al.
Biology Open|April 17, 2017
Reprogramming towards totipotency is greatly facilitated by synergistic effects of small moleculesKei Miyamoto, Yosuke Tajima, Koki Yoshida, et al.
Pageof 116

Showing results (1041-1050 of 1,158) with videos related to

Sort By:
Pageof 116
Dermatology (Basel, Switzerland)|February 3, 2021
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort PsobioteqFlorence Assan, Florence Tubach, Hugo Arlegui, et al.
The Journal of Cell Biology|August 14, 2023
Presynapses contain distinct actin nanostructuresDominic Bingham, Channa Elise Jakobs, Florian Wernert, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, UgandaImke H Bartelink, Rada M Savic, Grant Dorsey, et al.
Current Alzheimer Research|June 25, 2005
JLK inhibitors: isocoumarin compounds as putative probes to selectively target the gamma-secretase pathwayFrédéric Checler, Checler Frédéric, Cristine Alves da Costa, et al.
Nature Communications|December 1, 2021
Engineering of a fluorescent chemogenetic reporter with tunable color for advanced live-cell imagingHela Benaissa, Karim Ounoughi, Isabelle Aujard, et al.
Blood Advances|January 4, 2018
Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in miceMarijn A Gillissen, Greta de Jong, Martijn Kedde, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2016
New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseasesL Méry-Bossard, K Bagny, G Chaby, et al.
Oncoimmunology|June 28, 2021
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell responseDhon Roméo Makanga, Maxime Jullien, Gaëlle David, et al.
JAMA Dermatology|June 21, 2023
Hyperactivation of the JAK2/STAT5 Signaling Pathway and Evaluation of Baricitinib Treatment Among Patients With Eosinophilic CellulitisJohanna Morot, Ester Del Duca, Marine Chastagner, et al.
Biology Open|April 17, 2017
Reprogramming towards totipotency is greatly facilitated by synergistic effects of small moleculesKei Miyamoto, Yosuke Tajima, Koki Yoshida, et al.
Pageof 116